RxDoctor Payments Data

Steven Freedman

Neurology · Raleigh, NCNPI 1609891613

Payments from drug & device makers

$198,367in general payments, 2019–2025

Across 353 payments — averaging $561.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$109K
  • Roche Products Limited$27K
  • Biogen$22K
  • Alkermes, Inc.$22K
  • AstraZeneca$5K
  • Mallinckrodt Enterprises LLC$4K
  • plus $9K from 17 others

What the payments were for

  • Consulting fees$11,85028%
  • Speaking & faculty fees$20,54749%
  • Travel & lodging$5,57213%
  • Food & beverage$4,24610%
  • Education$850%

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$198,367 in reported general payments places this provider in the 85th percentile of 566 neurology providers in North Carolina.

See all neurology providers in North Carolina

Other neurology in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →